Literature DB >> 18079000

In vivo imaging of murine retinal ganglion cells.

Christopher K S Leung1, James D Lindsey, Jonathan G Crowston, Won-Kyu Ju, Qwan Liu, Dirk-Uwe Bartsch, Robert N Weinreb.   

Abstract

Current methods for in vivo retinal ganglion cells (RGCs) imaging involve either retrograde or intravitreal injection of chemical or biological tracers, which are invasive and may require repeated injection for serial long-term assessment. We have developed a confocal scanning laser ophthalmoscope technique (blue-light CSLO or bCSLO) to image retinal ganglion cells (RGCs) in mice expressing cyan fluorescent protein under the control of a Thy-1 promoter. Fluorescent spots corresponding to CFP-expressing retinal ganglion cells were discernable with the bCSLO. 96.1+/-2.6% of CFP expressing cells also were retrograde labeled with DiI indicating the bCSLO imaged fluorescent spots are RGCs. The imaging of Thy-1 promoter-driven CFP expression in these mice could serve as a sensitive indicator to reflect the integrity of RGCs, and provides a non-invasive method for longitudinal study of the mechanism of RGC degeneration and the effect of neuroprotective agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18079000     DOI: 10.1016/j.jneumeth.2007.10.018

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  30 in total

1.  Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy.

Authors:  Christopher Kai-shun Leung; James D Lindsey; Jonathan G Crowston; Chen Lijia; Sylvia Chiang; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

Review 2.  In vivo imaging methods to assess glaucomatous optic neuropathy.

Authors:  Brad Fortune
Journal:  Exp Eye Res       Date:  2015-06-03       Impact factor: 3.467

3.  Label-free nonlinear optical imaging of mouse retina.

Authors:  Sicong He; Cong Ye; Qiqi Sun; Christopher K S Leung; Jianan Y Qu
Journal:  Biomed Opt Express       Date:  2015-02-26       Impact factor: 3.732

4.  Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma.

Authors:  Kevin C Chan; Yu Yu; Shuk Han Ng; Heather K Mak; Yolanda W Y Yip; Yolandi van der Merwe; Tianmin Ren; Jasmine S Y Yung; Sayantan Biswas; Xu Cao; Ying Chau; Christopher K S Leung
Journal:  Acta Biomater       Date:  2019-06-06       Impact factor: 8.947

Review 5.  Assessing retinal ganglion cell damage.

Authors:  C A Smith; J R Vianna; B C Chauhan
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 6.  Advances in retinal ganglion cell imaging.

Authors:  S I Balendra; E M Normando; P A Bloom; M F Cordeiro
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

7.  Nerve fiber layer thinning lags retinal ganglion cell density following crush axonopathy.

Authors:  Gustavo C Munguba; Sanja Galeb; Yuan Liu; David C Landy; Daisy Lam; Andrew Camp; Sinthia Samad; Mary L Tapia; Richard K Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-16       Impact factor: 4.799

8.  Semi-automated, quantitative analysis of retinal ganglion cell morphology in mice selectively expressing yellow fluorescent protein.

Authors:  Ericka Oglesby; Harry A Quigley; Donald J Zack; Frances E Cone; Matthew R Steinhart; Jing Tian; Mary E Pease; Giedrius Kalesnykas
Journal:  Exp Eye Res       Date:  2011-12-22       Impact factor: 3.467

9.  Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma.

Authors:  Joaquin Tosi; Nan-Kai Wang; Jin Zhao; Chai Lin Chou; J Mie Kasanuki; Stephen H Tsang; Takayuki Nagasaki
Journal:  Mol Imaging Biol       Date:  2009-11-24       Impact factor: 3.488

10.  In vivo imaging of microscopic structures in the rat retina.

Authors:  Ying Geng; Kenneth P Greenberg; Robert Wolfe; Daniel C Gray; Jennifer J Hunter; Alfredo Dubra; John G Flannery; David R Williams; Jason Porter
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.